Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Messenger RNA-based vaccines: Past, present, and future directions in the context of the COVID-19 pandemic
Samagra Jain, Abhijeet K. Venkataraman, Marissa E. Wechsler, et al.
Advanced Drug Delivery Reviews (2021) Vol. 179, pp. 114000-114000
Open Access | Times Cited: 110

Showing 1-25 of 110 citing articles:

Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment
Yujing Huang, Xiaohan Guo, Yi Wu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 109
Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases
Jingxing Yang, Jen‐Chih Tseng, Guann‐Yi Yu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 423-423
Open Access | Times Cited: 80
Ultrasound-responsive low-dose doxorubicin liposomes trigger mitochondrial DNA release and activate cGAS-STING-mediated antitumour immunity
Chaoyu Wang, Ruoshi Zhang, Jia He, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 69
mRNA Technology in Modern Medicine: Review and Future Prospects
Heslley Machado Silva
Deleted Journal (2025) Vol. 2, pp. 1-1
Closed Access | Times Cited: 1
Advanced Biomaterials for Cell‐Specific Modulation and Restore of Cancer Immunotherapy
Shaobo Ruan, Yuanyu Huang, Mei He, et al.
Advanced Science (2022) Vol. 9, Iss. 16
Open Access | Times Cited: 42
mRNA-Based Vaccine for COVID-19: They Are New but Not Unknown!
Vivek P. Chavda, Gargi Jogi, Srusti Dave, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 507-507
Open Access | Times Cited: 30
An Overview of the Stability and Delivery Challenges of Commercial Nucleic Acid Therapeutics
Rahul G Ingle, Wei‐Jie Fang
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1158-1158
Open Access | Times Cited: 29
Successful batch and continuous lyophilization of mRNA LNP formulations depend on cryoprotectants and ionizable lipids
Alexander Lamoot, Joris Lammens, Emily De Lombaerde, et al.
Biomaterials Science (2023) Vol. 11, Iss. 12, pp. 4327-4334
Closed Access | Times Cited: 28
Vaccine development: Current trends and technologies
Renu Poria, Deepak Kala, Rupak Nagraik, et al.
Life Sciences (2023) Vol. 336, pp. 122331-122331
Closed Access | Times Cited: 26
Long-acting vaccine delivery systems
Pavan Walvekar, Pradeep Kumar, Yahya E. Choonara
Advanced Drug Delivery Reviews (2023) Vol. 198, pp. 114897-114897
Closed Access | Times Cited: 21
Antibiotic resistance and tolerance: What can drug delivery do against this global threat?
Juan Aparicio-Blanco, Nikhar Vishwakarma, Claus‐Michael Lehr, et al.
Drug Delivery and Translational Research (2024) Vol. 14, Iss. 6, pp. 1725-1734
Open Access | Times Cited: 11
Infectious eye disease in the 21st century—an overview
Gerry Clare, John H. Kempen, Carlos Pavésio
Eye (2024) Vol. 38, Iss. 11, pp. 2014-2027
Open Access | Times Cited: 10
Post-pandemic implications for crisis innovation: A technological innovation view
Éric Viardot, Alexander Brem, Petra A. Nylund
Technological Forecasting and Social Change (2023) Vol. 194, pp. 122680-122680
Closed Access | Times Cited: 19
Recent Developments in Vaccine Design: From Live Vaccines to Recombinant Toxin Vaccines
Sonal Gupta, Sabine Pellett
Toxins (2023) Vol. 15, Iss. 9, pp. 563-563
Open Access | Times Cited: 19
Polyplex designs for improving the stability and safety of RNA therapeutics
Satoshi Uchida, Chun Yin Jerry Lau, Makoto Oba, et al.
Advanced Drug Delivery Reviews (2023) Vol. 199, pp. 114972-114972
Closed Access | Times Cited: 18
A Comprehensive review on Pharmacokinetic Studies of Vaccines: Impact of delivery route, carrier-and its modulation on immune response
Saurav Kumar Jha, Mohammad Imran, Laxmi Akhileshwar Jha, et al.
Environmental Research (2023) Vol. 236, pp. 116823-116823
Closed Access | Times Cited: 18
Application prospect of circular RNA-based neoantigen vaccine in tumor immunotherapy
Mohan Li, Yian Wang, Pan Wu, et al.
Cancer Letters (2023) Vol. 563, pp. 216190-216190
Closed Access | Times Cited: 17
Emergence of mRNA vaccines in the management of cancer
Mohamad Irfan Mohamad Razif, Nabilah Nizar, Nur Hannah Zainal Abidin, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 629-642
Open Access | Times Cited: 17
Enabling mRNA Therapeutics: Current Landscape and Challenges in Manufacturing
Maryam Youssef, Cynthia Hitti, Julia Puppin Chaves Fulber, et al.
Biomolecules (2023) Vol. 13, Iss. 10, pp. 1497-1497
Open Access | Times Cited: 17
An update on strategies for optimizing polymer-lipid hybrid nanoparticle-mediated drug delivery: exploiting transformability and bioactivity of PLN and harnessing intracellular lipid transport mechanism
Taksim Ahmed, Fuh-Ching Franky Liu, Xiao Yu Wu
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 2, pp. 245-278
Closed Access | Times Cited: 5
Durable cross-protective neutralizing antibody responses elicited by lipid nanoparticle-formulated SARS-CoV-2 mRNA vaccines
Ki Hyun Bae, Bhuvaneshwari D O Shunmuganathan, Li Zhang, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5
New approach methodologies to assess wanted and unwanted drugs-induced immunostimulation
Valeria Bettinsoli, Gloria Melzi, I. Marchese, et al.
Current Research in Toxicology (2025) Vol. 8, pp. 100222-100222
Open Access
mRNA vaccine platforms: linking infectious disease prevention and cancer immunotherapy
Dariush Haghmorad, Majid Eslami, Niloufar Orooji, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 13
Open Access
Precision Vaccine Development: Cues From Natural Immunity
Soumik Barman, Dheeraj Soni, Byron Brook, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 23
Tissue resident memory T cells- A new benchmark for the induction of vaccine-induced mucosal immunity
Mariah Hassert, John T. Harty
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top